SAN CARLOS, Calif., Oct 23 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2008 on Thursday, November 6, 2008, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).
The press release and a live audio-only Webcast of the conference call
can be accessed through a link that is posted on the home page and Investor
Relations section of the Nektar website: http://www.nektar.com.
To access the conference call, follow these instructions:
Dial: 866.362.4666 (U.S.); 617.597.5313 (international)
Participant Passcode: 63756947 (Howard Robin is the host)
An audio replay will also be available shortly after the call and will
remain so through November 20, 2008.
To access the replay, follow these instructions:
Dial: 888-286-8010 (U.S.); 617-801-6888 (international)
Participant Passcode: 41304675
In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.
Nektar Therapeutics is a biopharmaceutical company developing novel
therapeutics based on its PEGylation and conjugate chemistry technology
platforms. Nektar's technology and drug development expertise have enabled
nine approved products for partners, which include leading
biopharmaceutical companies. Nektar is also developing a robust pipeline of
its own high-value therapeutics that addresses unmet medical needs by
leveraging and expanding its technology platforms to improve and enable
Stephan Herrera, 415-488-7699
Jennifer Ruddock, 650-631-4954
|SOURCE Nektar Therapeutics|
Copyright©2008 PR Newswire.
All rights reserved